BriaCell Therapeutics Corp. (TSX:BCT)
5.62
-0.08 (-1.40%)
May 2, 2025, 3:59 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-1.05M CAD
Market Cap
20.85M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jul 31, 2023 | 16 | 10 | 166.67% |
Jul 31, 2021 | 6 | 0 | - |
Aug 1, 2019 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Green Thumb Industries | 4,800 |
dentalcorp Holdings | 10,200 |
Sienna Senior Living | 12,263 |
Trulieve Cannabis | 6,000 |
Extendicare | 23,000 |
Curaleaf Holdings | 5,519 |
WELL Health Technologies | 1,507 |
Cronos Group | 459 |
BriaCell Therapeutics News
- 2 days ago - BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified - GlobeNewsWire
- 4 days ago - BriaCell Therapeutics closes $13.8M public offering - Seeking Alpha
- 4 days ago - BriaCell Therapeutics Announces Closing of $13.8 million Public Offering - GlobeNewsWire
- 4 days ago - BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development - GlobeNewsWire
- 8 days ago - BriaCell (BCTX) Prices Public Offering of Units to Raise $13.8 Million - GuruFocus
- 8 days ago - BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering - GlobeNewsWire
- 8 days ago - Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher - Benzinga
- 8 days ago - Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher - Benzinga